Hepatocellular carcinoma: present status and future prospects.
about
Viral hepatitis and hepatocellular carcinomaAntidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver diseaseAssociation between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysisMinnelide, a novel drug for pancreatic and liver cancerHcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinomaHCV infection-associated hepatocellular carcinoma in humanized miceExtract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathwayUse of magnetic resonance elastography for assessing liver functional reserve: A clinical studyDiagnosis of hepatocellular carcinoma.An early look at the Organ Procurement and Transplantation Network explant pathology form data.Expression of cytochrome P4502E1 gene in hepatocellular carcinoma.Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.Metastatic carcinoma of the oral region: An analysis of 21 cases.Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.Diffusion-weighted PROPELLER MRI for quantitative assessment of liver tumor necrotic fraction and viable tumor volume in VX2 rabbitsRising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005).Hepatocellular carcinoma in the world and the middle East.CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.The cooperative effect of p53 and Rb in local nanotherapy in a rabbit VX2 model of hepatocellular carcinoma.[Hepatocellular carcinoma in rural Burkina Faso Africa: contribution of ultrasound, about 58 cases].Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in ColombiaRadiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial.RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.Developments in liver transplantation.Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteinsObesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative HepatectomyAxl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma.Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patientsFirst human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinomaExpression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
P2860
Q21245597-6A13A4E0-C73D-42FC-9D51-123028586EB0Q24655078-2C8E8EBB-C32D-40CD-A4C8-38E1D84C6BFAQ26801941-44F3F9ED-BF57-4E09-9FB0-8C7018AF5F36Q27693346-D37B9F60-4940-4063-A324-FD12F7259AA5Q28304534-7DC089DA-F695-44EC-B3A9-05E08870BD7EQ28384465-BC4F3072-B36D-4AD4-A0E7-8FD8D055FD74Q28481696-07056ABB-3806-44B1-98E6-B4962BDA10DAQ30407621-194D3628-3E95-47D0-9F3A-F91B5D0F7012Q30490554-8E720FA2-8405-4166-AF27-8F15985EDBEDQ31057437-7B0D8BF7-8BB2-4AE9-99B3-174AD8E0B223Q31066257-33AFC782-539E-4EEB-8A5A-B08D4CF62BB4Q33257944-A32FD9D2-2F45-4476-B756-5A1E89F4F749Q33393492-6E6F0AB5-2095-47CE-AB45-B467A01B8E0CQ33443502-B882A760-3F8B-4EAA-87C4-176FFA53DA9AQ33532957-C35B2FAB-56E4-4BB2-93A9-85B54295FC7BQ33682891-F4F6D4E2-0082-40D4-BE6F-6A7E6A4D50D7Q33688047-627B1D09-036E-4135-9ED4-1C99B70B168BQ33859074-3CB95040-726D-48FF-9101-DC9E9C628F2CQ33935606-E61CDB11-4FF7-4963-A37A-060ADB59F7F0Q34077967-D64EEBE1-8BEA-455A-A70E-D38FCCDDC0FFQ34099104-D0EF4CE4-AF67-4E01-9995-D67F912D070FQ34134967-54F69730-39C9-4AF8-A7BC-920D540F6467Q34435766-C3F53726-9EE5-4F0F-A82B-88083B3FF4D6Q34669793-D4D0A8EC-013D-4E81-972D-0730A513B3EEQ35016771-17590039-5917-4C6F-A8AF-B8C960E3806EQ35211891-F3703F0A-A5C8-48D0-9D84-ED0333C49FB6Q35224439-588F0F77-D254-4FA6-A335-3B8879C680F4Q35273624-F7DD7200-6790-414C-BD8F-96841956FB4DQ35550266-71D36A0A-46CC-4EE8-9A0C-FF84FC2BE622Q35596527-0612049F-9932-4286-8D69-1432A3EB302DQ35596979-BBF5E193-8C40-4522-96D4-8C561AE43F34Q35597611-BAC22BD7-9DA8-4005-A7D4-E41781F56DB3Q36018500-E24FA3F3-2A92-4AFD-AAB8-4F2089D37745Q36180460-C4FB80F4-1A9B-42B8-9CB7-74314F6AD1D7Q36611050-438BC6C4-99C6-4DFE-8941-4E29B13AFDCDQ36615885-8B11CA64-38CD-48B2-AD57-C880126AFCD8Q36642970-887AD826-D81F-4E0D-9EFA-6CC2F673D08BQ36912160-4EF3F9CD-9F2A-4B8B-8B69-E517C19863A5Q36932065-82D1914F-099A-4F69-8333-DB4E6E1D67B6Q37133686-7054451F-889F-471A-9A88-80F3E4381A63
P2860
Hepatocellular carcinoma: present status and future prospects.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatocellular carcinoma: present status and future prospects.
@ast
Hepatocellular carcinoma: present status and future prospects.
@en
type
label
Hepatocellular carcinoma: present status and future prospects.
@ast
Hepatocellular carcinoma: present status and future prospects.
@en
prefLabel
Hepatocellular carcinoma: present status and future prospects.
@ast
Hepatocellular carcinoma: present status and future prospects.
@en
P1476
Hepatocellular carcinoma: present status and future prospects.
@en
P2093
Michel Beaugrand
P304
P356
10.1016/S0168-8278(02)00432-4
P478
38 Suppl 1
P577
2003-01-01T00:00:00Z